dc.creatorChun-Yet Lian, Eric
dc.creatorDiez-Ewald, María
dc.creatorWalter, Stephen D.
dc.creatorNúñez, Roger
dc.creatorLian, Jean-Fern
dc.creatorHarkness, Donald R.
dc.date2009-11-03
dc.date.accessioned2022-11-05T00:43:40Z
dc.date.available2022-11-05T00:43:40Z
dc.identifierhttps://produccioncientificaluz.org/index.php/investigacion/article/view/27967
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5135017
dc.descriptionThe posterior probability of each individual for normal or hemophilic carrier was calculated by multivariate discriminant analysis. When both factor VIII coagulant activity and factor VIII-related antigen were used, all of the 30 normal females and 18 of 20 obligatory carriers were correctly classified. When factor VIII coagulant activity and ristocetin cofactor activity were used, 97% of the normal females and 75% of carriers were correctly predicted. When all three parameters were taken into consideration in discriminant analysis, all normals and 17 of 20 carriers were correctly classified. We conclude that concurrent determination of both factor VIII coagulant activity and ristocetin cofactor activity can be used as an alternate or adjunctive method for detecting carriers.es-ES
dc.formatapplication/pdf
dc.languagespa
dc.publisherUniversidad del Zuliaes-ES
dc.relationhttps://produccioncientificaluz.org/index.php/investigacion/article/view/27967/28679
dc.rightsDerechos de autor 2016 Investigación Clínicaes-ES
dc.sourceInvestigación Clínica; Vol. 20 Núm. 3es-ES
dc.source2477-9393
dc.source0535-5133
dc.titlePrediction of Hemophilic Carriers: a New Statistical Approach Using Simultaneous Assays of Factor VIII Coagulant Activity, Factor VIII Related Antigen and Ristocetin Cofactor Activityes-ES
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución